NCT04845217

Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome

Efficacy of Peppermint Oil in a Randomized, Single-Blind, Placebo Controlled Trial in Women With Interstitial Cystitis/Bladder Pain Syndrome

• Status: Recruiting
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: University of Louisville · Academic / Other
• Sex: Female
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to assess the use of peppermint oil as a treatment for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).

Detailed description

After being informed about the study and potential risks, all participants will complete validated IC/BPS symptom questionnaires for baseline screening. Once participants meet eligibility requirements and give written informed consent they will be randomized in a 1:1 ratio to peppermint oil (200mg TID) or placebo (also TID). Participants will complete validated IC/BPS questionnaires and follow up surveys over 8 weeks.

Conditions

• Interstitial Cystitis

Interventions

Type	Name	Description
DRUG	Peppermint oil	Enteric coated peppermint oil taken by mouth three times daily for 8 weeks.
DRUG	Coconut Oil	Enteric coated coconut oil taken by mouth three times daily for 8 weeks

Timeline

• Start date: 2021-09-15
• Primary completion: 2023-06-01
• Completion: 2023-12-01
• First posted: 2021-04-14
• Last updated: 2022-08-22

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study